Samuel Weiss

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Sachamitr P, Ho JC, Ciamponi FE, et al. (2021) PRMT5 inhibition disrupts splicing and stemness in glioblastoma. Nature Communications. 12: 979
Michealraj KA, Kumar SA, Kim LJY, et al. (2020) Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma. Cell
Chesnelong C, Hao X, Cseh O, et al. (2019) SLUG Directs the Precursor State of Human Brain Tumor Stem Cells. Cancers. 11
Shen Y, Grisdale CJ, Islam SA, et al. (2019) Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments. Proceedings of the National Academy of Sciences of the United States of America
MacLeod G, Bozek DA, Rajakulendran N, et al. (2019) Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells. Cell Reports. 27: 971-986.e9
Chesnelong C, Restall I, Weiss S. (2019) Isolation and Culture of Glioblastoma Brain Tumor Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1869: 11-21
Luchman HA, Bozek D, Hao X, et al. (2019) Abstract 3084: BI-907828: A novel, potent MDM2 inhibitor, inhibits GBM brain tumor stem cellsin vitroand prolonged survival in orthotopic xenograft mouse models Cancer Research
Richards LM, Whitley O, Cavalli FM, et al. (2019) Abstract 967: Single-cell transcriptomics uncovers clonal heterogeneity linked to drug response and cellular phenotype in adult brain tumor stem cells Cancer Research. 79: 967-967
Bozek D, MacLeod G, Hao X, et al. (2019) STEM-21. INVESTIGATING DOT1L AS AN EPIGENETIC VULNERABILITY IN BRAIN TUMOR STEM CELLS Neuro-Oncology. 21: vi238-vi238
MacLeod G, Angers S, Dirks P, et al. (2019) GENE-31. IDENTIFICATION OF CORE AND CONTEXT-SPECIFIC FITNESS GENES IN GLIOBLASTOMA STEM CELLS VIA GENOME-WIDE CRISPR-Cas9 SCREENS Neuro-Oncology. 21: vi104-vi104